KENNEDY CAPITAL MANAGEMENT LLC - EAGLE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$575,384
-89.3%
36,486
-62.1%
0.01%
-88.3%
Q3 2021$5,366,000
+24.5%
96,191
-4.5%
0.12%
+29.0%
Q2 2021$4,310,000
-8.8%
100,704
-11.0%
0.09%
-2.1%
Q1 2021$4,724,000113,1800.10%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders